R. Will Charlton

Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study

Rohit Loomba, Eric Lawitz, Juan P. Frías et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 91 citations

Hepatology, Pharmacology, Pharmacological Issue +7

Assessing physical symptoms, daily functioning, and well‐being in children with achondroplasia

Kathryn M. Pfeiffer, Meryl Brod, Alden Smith et al. · American Journal of Medical Genetics Part A · 2020 · 53 citations · Full text

The relationship between addiction and reward bundling: an experiment comparing smokers and non‐smokers

Andre Hofmeyr, George Ainslie, R. Will Charlton et al. · Addiction · 2010 · 47 citations

Functioning and well‐being in older children and adolescents with achondroplasia: A qualitative study

Kathryn M. Pfeiffer, Meryl Brod, Alden Smith et al. · American Journal of Medical Genetics Part A · 2021 · 32 citations · Full text

The Novel GlycoPEGylated FGF21 Analog Pegozafermin Activates Human FGF Receptors and Improves Metabolic and Liver Outcomes in Diabetic Monkeys and Healthy Human Volunteers

Moti Rosenstock, Leo Tseng, Andrew L. Pierce et al. · Journal of Pharmacology and Experimental Therapeutics · 2023 · 20 citations · Full text